News and Views


Nature Medicine 15, 244 - 246 (2009)
doi:10.1038/nm0309-244

Choosing the right memory T cell for HIV

Genoveffa Franchini1

  1. Genoveffa Franchini is in the Animal Models and Retroviral Vaccines Section, US National Cancer Institute, Building 41 Room D-804, Bethesda, Maryland 20892-5065, USA. e-mail: franchig@mail.nih.gov


An experimental simian immunodeficiency virus vaccine boosts production of memory T cells at the site where the virus first contacts the body—in the mucosa (pages 293–299). The approach has the potential to result in more effective HIV vaccines than those currently under development.

Top



Extra navigation

Subscribe to Nature Medicine

Subscribe

Search PubMed for

Open Innovation Challenges

naturejobs

ADVERTISEMENT